MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    using latent class mixed modelling to profile Parkinson’s disease patients at risk of cognitive decline

    D. Pourzinal, R. Lawson, A. Yarnall, D. Burn, C. Williams-Gray, R. Barker, J. Yang, K. Mcmahon, J. O'Sullivan, G. Byrne, N. Dissanayaka (Herston, Australia)

    Objective: To determine the clinical profile of cognitive subtypes in Parkinson's disease (PD) based on their rate of change in global cognitive ability over time.…
  • 2023 International Congress

    Effects of motor and cognitive complex training on obstacle-crossing ability in participants with Parkinson’s disease

    R Y. Wang, C W. Hung, Y R. Yang (Taipei, Taiwan)

    Objective: To investigate the effects of complex walking training and motor-cognitive training on obstacle-crossing ability in Parkinson’s disease (PD). Background: Obstacle crossing needs both motor…
  • 2023 International Congress

    Mobile and electronic health-supported physical activity in Parkinson’s disease: A scoping review

    M. Bopp, J. Krell-Roesch, Y. Geda, S. Aslam, A. Woll (Karlsruhe, Germany)

    Objective: To conduct an overview of current research on mobile and electronic (m- and e-) health-supported physical activity (PA) programs in persons with Parkinson’s disease…
  • 2023 International Congress

    Assessing non-motor symptoms and associations with quality of life among patients in Korle-Bu Teaching Hospital, Ghana

    D. Brodie-Mends, F. Duodu, K. Nkromah, A. Akpalu (Accra, Ghana)

    Objective: To determine the prevalence and types of non-motor symptoms (NMS) and their relation to quality of life among Parkinson’s disease (PD) patients who attend…
  • 2023 International Congress

    Decreased occurrence of dyskinesia when combining amantadine to L-DOPA in early Parkinson disease (PD): the PREMANDYSK trial

    O. Rascol, F. Ory-Magne, JP. Azulay, L. Defebvre, JL. Houeto, D. Maltete, P. Remy, A. Foubert-Samier, A. Sommet, C. Thalamas, S. Thobois, JC. Corvol, N. Ns-Park/fcrin (Toulouse, France)

    Objective: To assess amantadine effects on dyskinesia and other PD symptoms when adjunct to L-DOPA in early PD. Background: Amantadine is efficacious on L-DOPA-induced dyskinesia…
  • 2023 International Congress

    Progressive cortical cerebrovascular reactivity reduction occurs in Parkinson’s disease: a longitudinal study

    LR. Jin (Shanghai, China)

    Objective: In the longitudinal study, we aimed to investigate regional cerebrovascular reactivity (CVR) changes in the patients with PD at baseline and during a 2-year…
  • 2023 International Congress

    Genetic subtypes of Parkinson’s disease in a Colorado clinic

    M. Lafreniere, G. Bosma, E. Forbes (Aurora, USA)

    Objective: The objective of this study is to investigate the natural history of genetic subtypes of Parkinson’s disease (PD) and characterize the genetic architecture of…
  • 2023 International Congress

    Parkinson’s disease and physiotherapy: perspectives in functional health education and innovation in digital media

    S. Souza, A. Silva, V. Israel (CURIIBA, Brazil)

    Objective: To identify and develop virtual functional health education content aimed at people with PD and to verify the reach profile on social media. Background:…
  • 2023 International Congress

    Impact of deep brain stimulation of the subthalamic nuclei on non-motor symptoms in Parkinson’s disease: a monocentric prospective study with a 12-month follow-up

    V. Leclercq, V. Donckels, E. Hanon, S. Dethy (Sint-Pieters-Leeuw, Belgium)

    Objective: The aim of the study is to evaluate the evolution of non-motor symptoms in Parkinson's disease (PD) in patients treated with deep brain stimulation…
  • 2023 International Congress

    Long-term safety and durability of effect of ecopipam in pediatric patients with Tourette Syndrome: Results of a 12-month open-label extension (OLE) study

    D. Gilbert, D. Kim, M. Miller, S. Horine, K. Saljooqi, G. Karkanias, S. Wanaski, T. Cunniff (Cincinnati, USA)

    Objective: Assess the safety and durability of effect of long-term treatment with ecopipam in pediatric patients with Tourette syndrome (TS). Background: TS is a childhood-onset…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley